Key result
Multiple testing problems in regulatory applications present fundamental challenges for developers of innovative pharmaceutical products.
Key points are not available for this paper at this time.
Poses ongoing hurdles for product developers; leaves open refined statistical frameworks for regulatory submissions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chuang‐Stein et al. (2009) studied this question. Multiple testing problems in regulatory applications present fundamental challenges for developers of innovative pharmaceutical products.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: